Virgolino Ana, Ferraz Carolina, Nicolau Vanessa, Cortes Rui, Pereira Aida, Maltez Fernando, Caldas João Paulo, Lourinho João, Alves Maria, Caetano Inês, Teixeira Tiago, Casella Isabel, Soeiro Cristina, Meseiro Andreia, Pinho Raquel, Ribeiro Andreia, Serrão Rosário, Antunes Francisco
Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.
Lean Health Portugal, 1749-016 Lisboa, Portugal.
Healthcare (Basel). 2025 Jul 25;13(15):1812. doi: 10.3390/healthcare13151812.
: The timely initiation of antiretroviral therapy (ART) in persons living with HIV (PLWH) can improve clinical outcomes. However, ART commencement is often delayed. Portugal, despite having one of the highest new HIV diagnosis rates within the European Union, has limited available national-level data. Prior evidence from 2017 to 2018 suggests that the average time to ART initiation exceeds the recommendations for optimal patient benefits. This study aimed to determine the number of days from the first hospital appointment to the commencement of ART among newly diagnosed PLWH in Portugal between 2017 and 2022 at the national level and across different hospitals. It was hypothesized that newly diagnosed PLWH in Portugal experience a delay in ART initiation beyond the recommended timeframe. : A retrospective analysis of records from Portuguese public tertiary care hospitals, which manage most HIV patients, was conducted. Descriptive statistics (measures of central tendency, dispersion, and frequency) were applied, along with association tests and a binary logistic regression model to examine factors influencing the timing of ART initiation. : A total of 2229 cases (out of 3434 received) from 19 hospitals were considered eligible. The median time interval between the first hospital appointment and ART initiation was 29.00 days, with a decreasing tendency between 2017 and 2022. Patients initiating therapy after 14 days had higher CD4 levels and lower viral loads compared to those starting within 14 days, with statistical significance. : Continuous and regular monitoring of key indicators, such as the time to ART initiation, is pivotal for assessing the effectiveness of HIV treatment programs and pinpointing areas in need of improvement.
对感染艾滋病毒者(PLWH)及时启动抗逆转录病毒疗法(ART)可改善临床结果。然而,ART开始时间往往延迟。葡萄牙尽管是欧盟内新艾滋病毒诊断率最高的国家之一,但全国层面可用数据有限。2017年至2018年的先前证据表明,开始ART的平均时间超过了实现最佳患者获益的建议时间。本研究旨在确定2017年至2022年期间葡萄牙新诊断的PLWH在全国层面及不同医院从首次医院就诊到开始ART的天数。据推测,葡萄牙新诊断的PLWH在ART启动方面存在超出推荐时间范围的延迟。 对管理大多数艾滋病毒患者的葡萄牙公立三级护理医院的记录进行了回顾性分析。应用了描述性统计(集中趋势、离散度和频率测量)以及关联测试和二元逻辑回归模型来检查影响ART启动时间的因素。 共纳入了19家医院的2229例病例(在收到的3434例中)。首次医院就诊与开始ART之间的中位时间间隔为29.00天,2017年至2022年期间呈下降趋势。与在14天内开始治疗的患者相比,14天后开始治疗的患者CD4水平更高,病毒载量更低,具有统计学意义。 持续定期监测关键指标,如开始ART的时间,对于评估艾滋病毒治疗项目的有效性和确定需要改进的领域至关重要。
Healthcare (Basel). 2025-7-25
Cochrane Database Syst Rev. 2014-5-22
Cochrane Database Syst Rev. 2012-7-11
Cochrane Database Syst Rev. 2010-3-17
Cochrane Database Syst Rev. 2018-1-22
Health Technol Assess. 2001
Cochrane Database Syst Rev. 2010-3-17
Healthcare (Basel). 2021-6-25